Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
cis-Halovinylthioacetamido side chain, a new effective structural element for 7 beta-substitution in cephem and oxacephem antibiotics. II. 7 beta-cis-Fluorovinylthioacetamino-7 alpha-methoxy-1-oxacephems.
Nishitani Y, Aoki T, Konoike T, Takahashi H, Yamamoto S, Nishino Y, Yoshioka M, Tsuji T, Komatsu Y, Matsuura S, et al. Nishitani Y, et al. J Antibiot (Tokyo). 1988 Mar;41(3):332-42. doi: 10.7164/antibiotics.41.332. J Antibiot (Tokyo). 1988. PMID: 3366691 Free article.
New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
Yoshizawa H, Kubota T, Itani H, Ishitobi H, Miwa H, Nishitani Y. Yoshizawa H, et al. Among authors: nishitani y. Bioorg Med Chem. 2004 Aug 1;12(15):4211-9. doi: 10.1016/j.bmc.2004.05.022. Bioorg Med Chem. 2004. PMID: 15246097
A novel series of parenteral cephalosporins exhibiting potent activities against both Pseudomonas aeruginosa and other gram-negative pathogens. Part 2: Synthesis and structure-activity relationships.
Yamawaki K, Nomura T, Yasukata T, Tanimoto N, Uotani K, Miwa H, Yamano Y, Takeda K, Nishitani Y. Yamawaki K, et al. Among authors: nishitani y. Bioorg Med Chem. 2008 Feb 15;16(4):1632-47. doi: 10.1016/j.bmc.2007.11.028. Epub 2007 Nov 17. Bioorg Med Chem. 2008. PMID: 18065229
Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.
Yoshida O, Yasukata T, Sumino Y, Munekage T, Narukawa Y, Nishitani Y. Yoshida O, et al. Among authors: nishitani y. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3027-31. doi: 10.1016/s0960-894x(02)00664-9. Bioorg Med Chem Lett. 2002. PMID: 12372494
New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
Yoshizawa H, Kubota T, Itani H, Minami K, Miwa H, Nishitani Y. Yoshizawa H, et al. Among authors: nishitani y. Bioorg Med Chem. 2004 Aug 1;12(15):4221-31. doi: 10.1016/j.bmc.2004.05.021. Bioorg Med Chem. 2004. PMID: 15246098
225 results